Highest Performances (MAAS) had the highest return between December 13, 2023 and December 28, 2023 by a small-cap US stock, returning 182%.
| ASSET | DATE | % RETURN |
|---|---|---|
Highest Performances (MAAS) | 12/13/2023 - 12/28/2023 | 182% |
Wheels Up Experience (UP) | 12/13/2023 - 12/28/2023 | 161.04% |
Argo Blockchain PLC ADR (ARBK) | 12/13/2023 - 12/28/2023 | 159.87% |
Invivyd (IVVD) | 12/13/2023 - 12/28/2023 | 141.98% |
Canaan (CAN) | 12/13/2023 - 12/28/2023 | 128.46% |
Esperion Therapeutics (ESPR) | 12/13/2023 - 12/28/2023 | 108.11% |
Absci (ABSI) | 12/13/2023 - 12/28/2023 | 96.58% |
Altimmune (ALT) | 12/13/2023 - 12/28/2023 | 95.29% |
Sight Sciences (SGHT) | 12/13/2023 - 12/28/2023 | 88.74% |
Annexon (ANNX) | 12/13/2023 - 12/28/2023 | 88.07% |
Personalis (PSNL) | 12/13/2023 - 12/28/2023 | 86.51% |
Better Home & Finance (BETR) | 12/13/2023 - 12/28/2023 | 82.98% |
Loandepot (LDI) | 12/13/2023 - 12/28/2023 | 82% |
Bit Digital (BTBT) | 12/13/2023 - 12/28/2023 | 73.13% |
Solid Biosciences LLC (SLDB) | 12/13/2023 - 12/28/2023 | 66.17% |
DeFi Technologies (DEFT) | 12/13/2023 - 12/28/2023 | 58.89% |
MeiraGTx (MGTX) | 12/13/2023 - 12/28/2023 | 58.57% |
HIVE Blockchain Technologies (HIVE) | 12/13/2023 - 12/28/2023 | 56.6% |
Relmada Therapeutics (RLMD) | 12/13/2023 - 12/28/2023 | 55.97% |
Porch (PRCH) | 12/13/2023 - 12/28/2023 | 55.5% |
Galiano Gold (GAU) | 12/13/2023 - 12/28/2023 | 55% |
ADC Therapeutics (ADCT) | 12/13/2023 - 12/28/2023 | 54.37% |
Fulcrum Therapeutics (FULC) | 12/13/2023 - 12/28/2023 | 54.16% |
Ocugen (OCGN) | 12/13/2023 - 12/28/2023 | 53.45% |
TriSalus Life Sciences (TLSI) | 12/13/2023 - 12/28/2023 | 52.28% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
